Literature DB >> 9824158

The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

K D Huynh1, V J Bardwell.   

Abstract

Virtually all diffuse large cell lymphomas and a significant fraction of follicular lymphomas contain translocations and/or point mutations in the 5' non-coding region of the putative oncogene BCL-6, that are presumed to deregulate its expression. BCL-6 encodes a Cys2-His2 zinc finger transcriptional repressor with a POZ domain at its amino-terminus. The POZ (or BTB) domain, a 120-amino-acid motif, mediates homomeric and, in some proteins, heteromeric POZ-POZ interactions. In addition, the POZ domain is required for transcriptional repression of several proteins, including BCL-6. Using a yeast two-hybrid screen, we identified N-CoR and SMRT as BCL-6 interacting proteins. Both N-CoR and SMRT, which were originally identified as co-repressors for the unliganded nuclear thyroid hormone and retinoic acid receptors, are components of large complexes containing histone deacetylases. We show that the interaction between BCL-6 and these co-repressors is also detected in the more physiologically relevant mammalian two-hybrid assay. The POZ domain is necessary and sufficient for interaction with these co-repressors. BCL-6 and N-CoR co-localize to punctate regions of the nucleus. Furthermore, when BCL-6 is bound to its consensus recognition sequence in vivo, it can interact with N-CoR and SMRT. We find, in vitro, that POZ domains from a variety of other POZ domain-containing proteins, including the transcriptional repressor PLZF, as well as ZID, GAGA and a vaccinia virus protein, SalF17R, also interact with varying affinities with N-CoR and SMRT. We find that BCL-6 POZ domain mutations that disrupt the interaction with N-CoR and SMRT no longer repress transcription. In addition, these mutations no longer self associate suggesting that self interaction is required for interaction with the co-repressors and for repression. More recently N-CoR has also been implicated in transcriptional repression by the Mad/Mxi proteins. Our demonstration that N-CoR and SMRT interact with the POZ domain containing proteins indicates that these co-repressors are likely involved in the mediation of repression by multiple classes of repressors and may explain, in part, how POZ domain containing repressors mediate transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9824158     DOI: 10.1038/sj.onc.1202197

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  91 in total

1.  Transcriptional repression by the insulator protein CTCF involves histone deacetylases.

Authors:  M Lutz; L J Burke; G Barreto; F Goeman; H Greb; R Arnold; H Schultheiss; A Brehm; T Kouzarides; V Lobanenkov; R Renkawitz
Journal:  Nucleic Acids Res       Date:  2000-04-15       Impact factor: 16.971

2.  Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression.

Authors:  H Y Kao; M Downes; P Ordentlich; R M Evans
Journal:  Genes Dev       Date:  2000-01-01       Impact factor: 11.361

3.  Functional interaction of STAT5 and nuclear receptor co-repressor SMRT: implications in negative regulation of STAT5-dependent transcription.

Authors:  H Nakajima; P K Brindle; M Handa; J N Ihle
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

4.  The p120 catenin partner Kaiso is a DNA methylation-dependent transcriptional repressor.

Authors:  A Prokhortchouk; B Hendrich; H Jørgensen; A Ruzov; M Wilm; G Georgiev; A Bird; E Prokhortchouk
Journal:  Genes Dev       Date:  2001-07-01       Impact factor: 11.361

5.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

6.  In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

Authors:  A Melnick; K F Ahmad; S Arai; A Polinger; H Ball; K L Borden; G W Carlile; G G Prive; J D Licht
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins.

Authors:  D Read; M J Butte; A F Dernburg; M Frasch; T B Kornberg
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

8.  Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.

Authors:  Micah D Gearhart; Connie M Corcoran; Joseph A Wamstad; Vivian J Bardwell
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

9.  AMPKα2 exerts its anti-inflammatory effects through PARP-1 and Bcl-6.

Authors:  Brendan Gongol; Traci Marin; I-Chen Peng; Brian Woo; Marcy Martin; Stephanie King; Wei Sun; David A Johnson; Shu Chien; John Y-J Shyy
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

10.  Sequential transcription factor targeting for diffuse large B-cell lymphomas.

Authors:  Leandro C Cerchietti; Jose M Polo; Gustavo F Da Silva; Pedro Farinha; Rita Shaknovich; Randy D Gascoyne; Steven F Dowdy; Ari Melnick
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.